ERBB2 and HIV-1 infection: Two main versions of the simulator are currently under development: the HIV simulator, designed to model responses to HIV-1 infection [2] and the SimTriplex simulator, designed to model vaccine schedules for the immunoprevention of mammary carcinoma in HER-2/neu transgenic mouse [3].